Phase II study of prophylactic oral administration of diltiazem for atrial fibrillation after lung resectio
Phase 2
Recruiting
- Conditions
- atrial fibrillation after lung resection
- Registration Number
- JPRN-UMIN000001691
- Lead Sponsor
- Department of Surgical Oncology, Hokkaido University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 124
Inclusion Criteria
Not provided
Exclusion Criteria
unstable angina pectoris, myocardial infarction or heart failure with in 3 months uncontrolled diabetes or hypertension active infection gastrointestinal bleeding diarrhea ileus chronic Af already taking diltiazem or other calcium blocker AV block more than 2nd degree sick sinus syndrome past history of severe allergy uncontrolled pleural effusion, ascites or pericardial fluid in pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of atrial fibrillation after lung resection
- Secondary Outcome Measures
Name Time Method Degree and frequency of adverse event (hypotension, bradycardia, etc.)